Abraham J Wu1, Eric Williams2, Ankit Modh3, Amanda Foster3, Ellen Yorke2, Andreas Rimner3, Andrew Jackson2. 1. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. Electronic address: wua@mskcc.org. 2. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, USA. 3. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA.
Abstract
BACKGROUND AND PURPOSE: Stereotactic body radiotherapy (SBRT) to central lung tumors can cause esophageal toxicity, but little is known about the incidence or risk factors. We reviewed central lung SBRT patients to identify dosimetric factors predictive of esophageal toxicity. MATERIALS AND METHODS: We assessed esophageal toxicity in 125 SBRT patients. Using biological equivalent doses with α/β=10 Gy (BED₁₀), dose-volume histogram variables for the esophagus (Dv and Vd) were assessed for correlation with grade ⩾2 acute toxicity. RESULTS: Incidence of grade ⩾2 acute toxicity was 12% (n=15). Highly significant logistic models were generated for D₅cc and Dmax (p<0.001). To keep the complication rate <20%, the model requires that D₅cc⩽26.3 BED₁₀. At 2 years, the probability of complication with BED₁₀D₅cc>14.4 Gy was 24%, compared to 1.6% if ⩽14.4 Gy. CONCLUSIONS: This novel analysis provides guidelines to predict acute esophageal toxicity in lung SBRT. Dose to the hottest 5cc and Dmax of the esophagus were the best predictors of toxicity. Converting the BED₁₀ limits to physical doses, D₅cc to the esophagus should be kept less than 16.8, 18.1 and 19.0 Gy for 3, 4, and 5 fractions, respectively, to keep the acute toxicity rate <20%.
BACKGROUND AND PURPOSE: Stereotactic body radiotherapy (SBRT) to central lung tumors can cause esophageal toxicity, but little is known about the incidence or risk factors. We reviewed central lung SBRT patients to identify dosimetric factors predictive of esophageal toxicity. MATERIALS AND METHODS: We assessed esophageal toxicity in 125 SBRT patients. Using biological equivalent doses with α/β=10 Gy (BED₁₀), dose-volume histogram variables for the esophagus (Dv and Vd) were assessed for correlation with grade ⩾2 acute toxicity. RESULTS: Incidence of grade ⩾2 acute toxicity was 12% (n=15). Highly significant logistic models were generated for D₅cc and Dmax (p<0.001). To keep the complication rate <20%, the model requires that D₅cc⩽26.3 BED₁₀. At 2 years, the probability of complication with BED₁₀D₅cc>14.4 Gy was 24%, compared to 1.6% if ⩽14.4 Gy. CONCLUSIONS: This novel analysis provides guidelines to predict acute esophageal toxicity in lung SBRT. Dose to the hottest 5cc and Dmax of the esophagus were the best predictors of toxicity. Converting the BED₁₀ limits to physical doses, D₅cc to the esophagus should be kept less than 16.8, 18.1 and 19.0 Gy for 3, 4, and 5 fractions, respectively, to keep the acute toxicity rate <20%.
Authors: J A Abelson; J D Murphy; B W Loo; D T Chang; M E Daly; E A Wiegner; S Hancock; S D Chang; Q-T Le; S G Soltys; I C Gibbs Journal: Dis Esophagus Date: 2011-12-13 Impact factor: 3.429
Authors: Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin Journal: Med Phys Date: 2010-08 Impact factor: 4.071
Authors: Andrew Jackson; Lawrence B Marks; Søren M Bentzen; Avraham Eisbruch; Ellen D Yorke; Randal K Ten Haken; Louis S Constine; Joseph O Deasy Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Joseph O Deasy; Søren M Bentzen; Andrew Jackson; Randall K Ten Haken; Ellen D Yorke; Louis S Constine; Ashish Sharma; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Joost J Nuyttens; Noelle C van der Voort van Zyp; John Praag; Shafak Aluwini; Rob J van Klaveren; Cornelis Verhoef; Peter M Pattynama; Mischa S Hoogeman Journal: Radiother Oncol Date: 2012-01-20 Impact factor: 6.280
Authors: Bryan P Rowe; Daniel J Boffa; Lynn D Wilson; Anthony W Kim; Frank C Detterbeck; Roy H Decker Journal: J Thorac Oncol Date: 2012-09 Impact factor: 15.609
Authors: Jing Zhao; Ellen D Yorke; Ling Li; Brian D Kavanagh; X Allen Li; Shiva Das; Moyed Miften; Andreas Rimner; Jeffrey Campbell; Jinyu Xue; Andrew Jackson; Jimm Grimm; Michael T Milano; Feng-Ming Spring Kong Journal: Int J Radiat Oncol Biol Phys Date: 2016-03-25 Impact factor: 7.038
Authors: Feng-Ming Spring Kong; Vitali Moiseenko; Jing Zhao; Michael T Milano; Ling Li; Andreas Rimner; Shiva Das; X Allen Li; Moyed Miften; ZhongXing Liao; Mary Martel; Soren M Bentzen; Andrew Jackson; Jimm Grimm; Lawrence B Marks; Ellen Yorke Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-26 Impact factor: 8.013
Authors: Kylie H Kang; Christian C Okoye; Ravi B Patel; Shankar Siva; Tithi Biswas; Rodney J Ellis; Min Yao; Mitchell Machtay; Simon S Lo Journal: Cancers (Basel) Date: 2015-06-15 Impact factor: 6.639